PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New method helps link genomic variation to protein production

2012-11-07
(Press-News.org) Scientists have adopted a novel laboratory approach for determining the effect of genetic variation on the efficiency of the biological process that translates a gene's DNA sequence into a protein, such as hemoglobin, according to a presentation, Nov. 6, at the American Society of Human Genetics 2012 meeting in San Francisco.

In the 0.1% of the DNA that differs between any two individuals, scientists search for the biological mechanisms underlying human genetic differences, including disease susceptibility.

"How exactly these slight changes in the DNA affect the biology of the human body is not known in most cases," said Constantin Polychronakos, M.D., professor of pediatrics, experimental medicine and human genetics at McGill University, Montreal, Canada.

"We decided to investigate the possibility that some of these changes may alter the translation of RNA into protein, a question that had not been systematically examined before," he added.

Translation is the final stage of gene expression at which the gene's DNA recipe for a protein can be modified, said McGill University scientist Quan Li, Ph.D., who presented the research.

In general, genomic studies have focused on finding links between diseases and variation in DNA. However, the new study takes a big step toward understanding how that variation affects the production of proteins, which are the molecules that most directly affect health and disease.

The study was designed to determine the effect of single-nucleotide polymorphisms (SNPs), which are variations in the DNA sequence, on the process of translation, Dr. Li said.

Translation begins when a gene's DNA sequence is transcribed into the messenger RNA (mRNA) molecule that carries the transcript, or the blueprint for the protein encoded by the gene, to ribosomes, where proteins are manufactured in a cell.

Dr. Li and his colleagues developed a novel and scalable method that uses the binding of mRNAs to ribosomes as a proxy for translational efficiency of mRNAs that differ from one another because of SNPs.

"Because efficiently translated transcripts associate with multiple ribosomes while less active ones with fewer or no ribosomes, we hypothesized that functional transcripts would show a detectable shift in this distribution," said Dr. Li.

Huiqi Qu, Ph.D., co-investigator of this study and assistant professor at the University of Texas School of Public Health, Brownsville, said, "The results of the proof-of-principle pilot study have clearly shown translational differences between mRNAs that differ only slightly from one another can be detected at a transcriptome-wide scale."

The transcriptome refers to the multiple types of RNAs that function in a cell.

"This study may represent the 'tip of the iceberg,' and its application to larger sample sizes will facilitate a shift toward functional genomics," said Dr. Polychronakos. "Functional genomics tells us how genetic variation affects disease and points more directly toward possible therapies."

"It will add an important tool in the evaluation of genetic loci associated with complex disorders," Dr. Polychronakos added.

###The researchers' presentation is titled, "Translational cis-regulation of gene expression in the human genome: the effect of human single nucleotide polymorphisms."

About ASHG

The American Society of Human Genetics is the primary professional membership organization for nearly 8,000 human genetics specialists worldwide. The ASHG Annual Meeting is the world's largest gathering of human genetics professionals and a forum for renowned experts in the field.


ELSE PRESS RELEASES FROM THIS DATE:

Strong tobacco control policies in Brazil credited for more than 400,000 lives saved

Strong tobacco control policies in Brazil credited for more than 400,000 lives saved
2012-11-07
WASHINGTON – High cigarette prices, smoke-free air laws, marketing restrictions and other measures, all part of Brazil's strong tobacco control policies, are credited for a 50 percent reduction in smoking prevalence between 1989 and 2010. The reduction contributed to an estimated 420,000 lives saved during that time period. Those are the findings of a new study published today in PLOS Medicine by a team of researchers from Georgetown Lombardi Comprehensive Cancer Center and the Brazilian National Cancer Institute. Adding to the dramatic conclusion of the study, which ...

Regular physical activity increases life expectancy even if overweight

2012-11-07
People who do regular physical activity, such as brisk walking, live longer than those who don't do any leisure time exercise, even when overweight, reports a study by international researchers published in this week's PLOS Medicine. These findings are important because, according to the authors (led by Steven Moore from the National Cancer Institute in Bethesda, USA): "This finding may help convince currently inactive persons that a modest physical activity program is ''worth it'' for health benefits, even if it may not result in weight control." The researchers from ...

Anti-tobacco policies responsible for Brazil's big success in reducing smoking rates

2012-11-07
Smoking rates in Brazil have dropped by half over the past two decades thanks to strict tobacco control policies, according to a study by US and Brazilian researchers published in this week's PLOS Medicine. Using a modeling simulation study called Brazil SimSmoke, the authors from authors from Lombardi Comprehensive Cancer Center of Georgetown University in Washington DC and the Brazilian National Cancer Institute in Rio de Janeiro, calculated that 46% of the reduction in smoking rates between 1989 and 2010 (34.8% of Brazilian adults smoked in 1989 compared to 18.5% in ...

China health system reform needs more accountability

2012-11-07
In this week's PLOS Medicine, David Hipgrave from the University of Melbourne, Australia and colleagues discuss health system reform in China and argue that parallel reforms in governance, financing, and accountability are also needed to ensure health equity. ### Funding: No specific funding was received to write this article. Competing Interests: The authors have declared that no competing interests exist. The opinions expressed in this paper reflect the perspectives of the authors alone, and may not be inferred to represent the position of their parent institutions. Citation: ...

Small change in defibrillator therapy leads to huge benefits for heart patients

2012-11-07
A new study shows that defibrillators – devices designed to detect and correct dangerous heart rhythms – can help people with heart disease live longer, and with a much better quality of life, than they do now. A small, very simple change in the way physicians set or programmed the device led to a dramatic 80 to 90 percent reduction in inappropriate therapies – potentially painful and anxiety-provoking shocks delivered for rhythms that aren't dangerous or life threatening. And, to the authors' surprise, the new programming also significantly increased survival, lowering ...

NIH study finds leisure-time physical activity extends life expectancy as much as 4.5 years

NIH study finds leisure-time physical activity extends life expectancy as much as 4.5 years
2012-11-07
Leisure-time physical activity is associated with longer life expectancy, even at relatively low levels of activity and regardless of body weight, according to a study by a team of researchers led by the National Cancer Institute (NCI), part of the National Institutes of Health. The study, which found that people who engaged in leisure-time physical activity had life expectancy gains of as much as 4.5 years, appeared Nov. 6, 2012, in PLOS Medicine. In order to determine the number of years of life gained from leisure-time physical activity in adulthood, which translates ...

2 years out, patients receiving stem cell therapy show sustained heart function improvement

2 years out, patients receiving stem cell therapy show sustained heart function improvement
2012-11-07
LOS ANGELES – Marked sustained improvement in all patients with zero adverse effects. For a phase I clinical trial, these results are the Holy Grail. Yet researchers from the University of Louisville and Brigham and Women's Hospital today reported just such almost-never-attained data. In a Late-Breaking Clinical Trial session at the American Heart Association Scientific Sessions 2012 meeting, Roberto Bolli, M.D., of the University of Louisville and Piero Anversa, M.D., of Brigham and Women's Hospital, Boston, presented data from their groundbreaking research in the ...

Discovery may help nerve regeneration in spinal injury

2012-11-07
Scientists at the Universities of Liverpool and Glasgow have uncovered a possible new method of enhancing nerve repair in the treatment of spinal cord injuries. It is known that scar tissue, which forms following spinal cord injury, creates an impenetrable barrier to nerve regeneration, leading to the irreversible paralysis associated with spinal injuries. Scientists at Liverpool and Glasgow have discovered that long-chain sugars, called heparan sulfates, play a significant role in the process of scar formation in cell models in the laboratory. Research findings have ...

Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments

2012-11-07
Scientists in the United States have tested all possible pairings of the 100 cancer drugs approved for use in patients in order to discover whether there are any combinations not tried previously that are effective in certain cancers. Dr Susan Holbeck (PhD), a biologist in the Division of Cancer Treatment and Diagnosis at the National Cancer Institute (USA) will tell the 24th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland, today (Wednesday) that she and her colleagues have completed testing the 100 drugs, with 300,000 experiments ...

New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial

2012-11-07
A newly developed antibody targeting a signalling pathway that is frequently active in solid tumours has shown encouraging signs of efficacy in its first trial in humans, researchers will report at the 24th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland, today (Wednesday). [2] A patient with advanced malignant melanoma has shown signs of tumour shrinkage and has been receiving treatment for more than 30 weeks without any serious adverse side-effects. Other patients with advanced non-small cell lung cancer (NSCLC), mesothelioma, ...

LAST 30 PRESS RELEASES:

UCalgary researchers pursue new approach to manage deadly lung scarring

Psychotherapy can be readily integrated into brief “med-check” psychiatry visits

‘Wiggling’ atoms may lead to smaller, more efficient electronics

Alliance webinar highlights latest advances in cancer treatment

Climate change could drastically reduce aquifer recharge in Brazil

$1.7M DOD grant funds virtual cancer center to support research into military health

Brain organoids could unlock energy-efficient AI

AI-powered CRISPR could lead to faster gene therapies, Stanford Medicine study finds

Shared genetic mechanisms underpin social life in bees and humans

Prescribed opioid pain medications during pregnancy likely aren’t associated with increased risk of autism, ADHD

Sustainable, plant-based diet benefits both human and planetary health

IU researchers find that opioid pain meds prescribed during pregnancy do not cause increased risk of autism or ADHD

Holocaust testimony is AI litmus test, and it fails

Preventing corruption in the lymph nodes

Older adults with hydrocephalus benefit from shunt surgery

Strong-confinement low-index-rib-loaded waveguide structure for etchless thin-film integrated photonics

Kidney transplant rejection associated with changes in lymphatic vessels, new research shows

EWRR becomes an official EULAR Congress

How HIV enters the genome – Researchers identify previously unknown mechanism

Scientists create a mathematical model that explains esophageal motility disorders

As pesticides and wildfires rise, kids with cancer need resources

New research suggests integrating behavioral health services in pediatric primary care can reduce symptoms

Monitoring underwater bridge tunnels with the help of high-energy muons

Fast traffic algorithm could improve real-time traffic forecasts

Integrated behavioral health services and psychosocial symptoms in children

Disparities in utilization of uterine fibroid embolization

Chapman University research reveals tropical rainforest soils may fuel climate change as the Earth warms – Accelerating global warming

Older adults with Parkinson’s disease have increased brain amyloid without dementia

Deep learning model estimates cancer risk of lung nodules

Study reveals how different messages motivate people to take conservation actions

[Press-News.org] New method helps link genomic variation to protein production